Ketoral is a medicine containing the active ingredient(s) ketorolac. On this page you will find out more about Ketoral, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: ketorolac
Over 65 years of age?
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Information for medicine and pack size:
Ketoral 30 mg/mL injection solution, 5 x 1 mL syringes
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Short-term management of moderately severe, acute pain following surgical procedures. The total duration of ketorolac use should not exceed five days. It is recommended that parenteral ketorolac be used in the immediate postoperative period. Patients can then be converted to an oral formulation (dependent on their analgesic needs). See Dosage and Administration, Conversion from parenteral to oral therapy. The total period of treatment utilising the oral and/or intramuscular route of administration is not to exceed five days. General Ketoral is not recommended for use as an obstetric preoperative medication or for obstetric analgesia because it has not been adequately studied for use in these circumstances and because of the known effects of drugs that inhibit prostaglandin biosynthesis on uterine contraction and fetal circulation. There is no satisfactory evidence for the use of Ketoral in acute exacerbations of chronic painful inflammatory conditions (e.g. rheumatoid arthritis or osteoarthritis).
Table of characteristics
|Visual appearance||Clear, pale, yellow solution free from particles|
|Dosage Form||Injection, solution|
|Route of administration||Intramuscular|
5's: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||Protect from Light|
|Life time||2 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.